Diagnostic Challenges in Pleural Mesothelioma
Cancers · 25.04.2026 · 18 (9) · 1374
DOI: 10.3390/cancers18091374 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 25.04.2026. Verfasst von Moshe Lapidot und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Surgery, Lung Center and International Mesothelioma Program, Brigham and Women's Hospital and Harvard Medical School, Boston, MA…. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Accurate diagnosis of PM and precise histologic subtyping are critical for optimal therapeutic decision-making, as treatment strategies—including chemotherapy, immunotherapy, or multimodality approaches—are largely subtype-dependent. Because of the several-decade latency between fiber inhalation and symptom onset, many cases are diagnosed at an advanced stage, when patients are already in poor clinical condition. As observed across multiple solid malignancies, earlier-stage diagnosis is associated with improved prognosis and expanded therapeutic options. However, the rarity of PM, the absence of validated screening strategies, and its nonspecific clinical and radiologic presentation—often mimicking both benign and metastatic pleural conditions, frequently result in diagnostic delay. Furthermore, the lack of pathognomonic histopathologic markers further complicates timely and definitive diagnosis. This review aims to delineate the epidemiologic, clinical, radiologic, and pathologic barriers that hinder accurate and early detection of PM. Current clinical evidence points to an urgent need to develop novel, validated biomarkers in PM, which will require a multidisciplinary approach.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Thoracic Surgery, Lung Center and International Mesothelioma Program, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
- Department of Thoracic Surgery, Galilee Medical Center, Nahariya 2210001, Israel.
- Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA.
Zitieren
APA
Lapidot, M., & Sattler, M. (2026). Diagnostic Challenges in Pleural Mesothelioma. Cancers, 18(9), 1374. https://doi.org/10.3390/cancers18091374
Vancouver
Lapidot M, Sattler M. Diagnostic Challenges in Pleural Mesothelioma. Cancers. 2026;18(9):1374. doi:10.3390/cancers18091374
BibTeX
@article{Lapidot2026,
author = {Lapidot, Moshe and Sattler, Martin},
title = {Diagnostic Challenges in Pleural Mesothelioma},
journal = {Cancers},
year = {2026},
volume = {18},
number = {9},
pages = {1374},
doi = {10.3390/cancers18091374}
}
EUVIMED